中國核電(601985.SH):部分董監高擬增持公司股份 人均增持額10萬-20萬元
格隆匯12月3日丨中國核電(601985.SH)公佈,公司近日收到公司董事、總經理張濤,副總經理顧健,董事會祕書羅小未,職工監事姜靜自願增持公司股份計劃的通知,基於對公司未來發展的信心和對公司長期投資價值的認可,上述人員計劃自2019年12月4日至2020年5月31日通過上海證券交易所繫統允許的方式增持公司股份,每人合計增持不低於人民幣10萬元,不高於人民幣20萬元。截至目前,上述人員均未持有公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.